Circulating Cytokines Predict the Development of Insulin Resistance in a Prospective Finnish Population Cohort.
CONTEXT Metabolic inflammation contributes to the development of insulin resistance (IR) but the roles of different inflammatory and other cytokines in this process remain unclear. OBJECTIVE We aimed at analyzing the value of different cytokines in predicting future IR. DESIGN, SETTING, AND PARTICIPANTS We measured the serum concentrations of 48 cytokines from a nationwide cohort of 2200 Finns (the Cardiovascular Risk in Young Finns Study) and analyzed their role as independent risk factors for predicting the development of IR 4 years later. MAIN OUTCOME MEASURES We used cross sectional regression analysis adjusted for known IR risk factors (high age, body mass index, systolic blood pressure, triglycerides, smoking, physical inactivity, and low high density lipoprotein cholesterol) C reactive protein and 37 cytokines to find the determinants of continuous baseline IR (defined by homeostatic model assessment) A logistic regression model adjusted for the known risk factors, baseline IR, and 37 cytokines was used to predict the future IR. RESULTS Several cytokines, often in a sex dependent manner, remained as independent determinants of current IR. In men, none of the cytokines was an independent predictive risk marker of future IR. In women, in contrast, IL 17 (odds ratio, 1.42 for 1 SD change in ln transformed IL 17) and IL 18 (odds ratio, 1.37) were independently associated with the future IR. IL 17 levels also independently predicted the development of incident future IR (odds ratio, 1.48) CONCLUSIONS The systemic levels of the T helper 1 cell cytokine IL 18 and the T helper 17 cell cytokine IL 17 thus may have value in predicting future insulin sensitivity in women independently of classical IR risk factors.
The Journal of clinical endocrinology and metabolism